Increased GLUT-1 expression could also be detected in BRAF wild-type skin lesions, such as squamous cell carcinomas (SCC) and AK (31) indicating that increased glucose metabolism contributes to tumor development of cutaneous neoplasia. The gene discussed is SLC2A1; the disease is squamous cell carcinoma.